Recovery

ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.

A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.

A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.

GLOW Blend combines BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

KLOW Blend 80mg combines KPV, BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

A three-amino-acid fragment of alpha-MSH explored mainly in laboratory and animal models of inflammatory signalling.

A human cathelicidin peptide with complex immune effects; topical wound studies do not establish injectable benefit.

A thymosin beta-4-associated product whose identity and human evidence must not be assumed from its marketing name.

A synthetic version of a thymic peptide with country-specific approvals and mixed clinical evidence across settings.

VIP 5mg is a naturally occurring neuropeptide, offered in a branded pre-filled pen with case only following online consultation and clinician approval.